CompoAtlas

利協清軟膠囊食品

利協清軟膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
1149058963
Chinese name
利協清軟膠囊食品
English name
NEW E.G.S LISHACHE CAPSULE
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
安利行有限公司
Registration date
2025-08-28
Published validity end
2030-08-28

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
SALMON OILSALMON OILHuile de saumon
GINKGO BILOBA L.GINKGO BILOBA L.Not identified
SHARK LIVER OILSHARK LIVER OILNot identified
COENZYME Q10COENZYME Q10Ubiquinone
GRAPE SEED OILGRAPE SEED OILNot identified
BORAGE SEED OILBORAGE SEED OILNot identified
L-PHENYLALANINEL-PHENYLALANINENot identified
DL-ALPHA-TOCOPHERYL ACETATE(VITAMIN E)DL-ALPHA-TOCOPHERYL ACETATE(VITAMIN E)Vitamine E
GARLIC OILGARLIC OILNot identified
LECITHINLECITHINNot identified
GELATINGELATINNot identified
GLYCEROLGLYCEROLGlycérol
WATERWATERNot identified
FAST GREEN FCFFAST GREEN FCFNot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
SORBIC ACIDSORBIC ACIDNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
利協清軟膠囊食品
Active ingredients
SALMON OIL;;GINKGO BILOBA L.;;SHARK LIVER OIL;;COENZYME Q10;;GRAPE SEED OIL;;BORAGE SEED OIL;;L-PHENYLALANINE;;DL-ALPHA-TOCOPHERYL ACETATE(VITAMIN E);;GARLIC OIL;;LECITHIN;;GELATIN;;GLYCEROL;;WATER;;FAST GREEN FCF;;TITANIUM DIOXIDE;;SORBIC ACID;;
Valid until
1190828
Registration number
1149058963
Licence holder
安利行有限公司
Registration date
1140828
Published reference
DHC0B490589633
Published English name
NEW E.G.S LISHACHE CAPSULE

Official source

View the official register, number 1149058963

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • GINKGO BILOBA L.
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

  • COENZYME Q10
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line